abstract |
A pharmaceutical composition for treatment of inflammation is disclosed which utilizes 3,7,11,15-tetramethyi-2,4,6,10,14-hexadecapentaenoic acid represented by the following chemical structural formula:n or a salt thereof, as the active ingredient. |